Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

£5m single-case MRSA compensation is "NHS wake-up call"

This article was originally published in Clinica

Executive Summary

A UK NHS patient is to receive record-breaking compensation of £5m ($9.8m) for damages in relation to contracting a strain of methicillin-resistant Staphylococcus aureus (MRSA). The infection was contracted following an operation at London's Chelsea and Westminster hospital, in 2004. The amount, which far exceeds normal compensation levels, is being awarded (in principle, Clinica understands) to a television celebrity for the seriousness and career-damaging sequelae of the infection. The payout is comparable to the total MRSA compensation awarded during 2002-06. Nevertheless, it was welcomed by the Patients Association as a "wake-up call for the NHS" to tighten infection controls. Almost 6,400 cases of MRSA were recorded in England in 2007.

You may also be interested in...



Pipeline Acquisitions, Co-Promotion Deals, To Drive Ipsen

Ipsen’s business strategy calls for accessing external innovation across its pipeline, combined with geographic expansion, realizing the unmet potential of its marketed products and business efficiencies in manufacturing and operations.

Biden COVID-19 Plan Would Grow Domestic Manufacturing Base

The proposal, which would increase capacity for pandemic supplies, is similar to ideas President Trump embraced pre-pandemic.

People On The Move: Appointments At Sanofi, Enzymatica And Bayer

Sanofi has named the head of its new API business; Sweden's Enzymatica has hired talent from J&J and L'Oreal; and Bayer has a new transformation officer.

Topics

UsernamePublicRestriction

Register

LL1135415

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel